tyrosyl-seryl(o-t-butyl)-glycyl-phenylalanyl-leucyl-threonine(o-t-butyl) has been researched along with cyprodime in 1 studies
| Studies (tyrosyl-seryl(o-t-butyl)-glycyl-phenylalanyl-leucyl-threonine(o-t-butyl)) | Trials (tyrosyl-seryl(o-t-butyl)-glycyl-phenylalanyl-leucyl-threonine(o-t-butyl)) | Recent Studies (post-2010) (tyrosyl-seryl(o-t-butyl)-glycyl-phenylalanyl-leucyl-threonine(o-t-butyl)) | Studies (cyprodime) | Trials (cyprodime) | Recent Studies (post-2010) (cyprodime) |
|---|---|---|---|---|---|
| 15 | 0 | 0 | 51 | 0 | 24 |
| Protein | Taxonomy | tyrosyl-seryl(o-t-butyl)-glycyl-phenylalanyl-leucyl-threonine(o-t-butyl) (IC50) | cyprodime (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0473 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0473 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0473 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borsodi, A; Garzon, J; Hutcheson, DM; Maldonado, R; Rodriguez-Diaz, M; Roques, BP; Sánchez-Blazquez, P; Schmidhammer, H | 1 |
1 other study(ies) available for tyrosyl-seryl(o-t-butyl)-glycyl-phenylalanyl-leucyl-threonine(o-t-butyl) and cyprodime
| Article | Year |
|---|---|
Use of selective antagonists and antisense oligonucleotides to evaluate the mechanisms of BUBU antinociception.
Topics: Analgesics; Animals; Male; Mice; Morphinans; Naltrexone; Narcotic Antagonists; Oligonucleotides, Antisense; Oligopeptides; Pain Measurement; Receptors, Opioid, delta; Receptors, Opioid, mu | 1999 |